1. Home
  2. JQC vs INMD Comparison

JQC vs INMD Comparison

Compare JQC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

JQC

Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

HOLD

Current Price

$4.82

Market Cap

709.5M

Sector

Finance

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$15.18

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JQC
INMD
Founded
2003
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
709.5M
842.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
JQC
INMD
Price
$4.82
$15.18
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$17.33
AVG Volume (30 Days)
538.3K
531.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
11.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.74
Revenue Next Year
N/A
$3.26
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$12.72
52 Week High
$5.58
$16.74

Technical Indicators

Market Signals
Indicator
JQC
INMD
Relative Strength Index (RSI) 57.25 53.29
Support Level $4.76 $14.94
Resistance Level $4.87 $15.23
Average True Range (ATR) 0.04 0.25
MACD 0.01 -0.06
Stochastic Oscillator 75.00 35.61

Price Performance

Historical Comparison
JQC
INMD

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: